Overview

Levosimendan Versus Dobutamine in Shock Patients

Status:
Unknown status
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Wentworth Area Health Services
Collaborator:
Abbott
Treatments:
Dobutamine
Simendan